Updated
Reviewed
Jun. 23, 2022
Appendix B: Acronyms
Acronym | Name |
---|---|
ACTG | AIDS Clinical Trials Group |
ANRS | National Agency for AIDS Research (France) |
ARROW | Anti-retroviral research for Watoto |
ATHENA | AIDS Therapy Evaluation in the Netherlands |
ATLAS | Antiretroviral Therapy as Long-Acting Suppression |
ATN | Adolescent Trials Network |
CHAPAS | Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens |
CHER | Children with HIV Early Antiretroviral Therapy |
DIONE | A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents |
ENCORE | Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy |
FLAIR | First Long-Acting Injectable Regimen |
HPPM | HIV Paediatric Prognostic Markers |
HPTN | HIV Prevention Trials Network |
IMPAACT | International Maternal Pediatric Adolescent AIDS Clinical Trials |
MOCHA | More Options for Children and Adolescents |
NEVEREST | Nevirapine Resistance Study |
PACTG | Pediatric AIDS Clinical Trials Group |
PENPACT | Trial run in collaboration between PENTA and PACTG/IMPAACT |
PENTA | Paediatric European Network for Treatment of AIDS |
PHACS | Pediatric HIV/AIDS Cohort Study |
PREDICT | Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV |
PROMOTE | PEPFAR PROMise Ongoing Treatment Evaluation |
SBIRT | Screening, Brief Intervention, and Referral to Treatment |
SMILE | Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children |
START | Strategic Timing of AntiRetroviral Treatment |
Appendix B: Acronyms
Acronym | Name |
---|---|
ACTG | AIDS Clinical Trials Group |
ANRS | National Agency for AIDS Research (France) |
ARROW | Anti-retroviral research for Watoto |
ATHENA | AIDS Therapy Evaluation in the Netherlands |
ATLAS | Antiretroviral Therapy as Long-Acting Suppression |
ATN | Adolescent Trials Network |
CHAPAS | Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens |
CHER | Children with HIV Early Antiretroviral Therapy |
DIONE | A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents |
ENCORE | Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy |
FLAIR | First Long-Acting Injectable Regimen |
HPPM | HIV Paediatric Prognostic Markers |
HPTN | HIV Prevention Trials Network |
IMPAACT | International Maternal Pediatric Adolescent AIDS Clinical Trials |
MOCHA | More Options for Children and Adolescents |
NEVEREST | Nevirapine Resistance Study |
PACTG | Pediatric AIDS Clinical Trials Group |
PENPACT | Trial run in collaboration between PENTA and PACTG/IMPAACT |
PENTA | Paediatric European Network for Treatment of AIDS |
PHACS | Pediatric HIV/AIDS Cohort Study |
PREDICT | Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV |
PROMOTE | PEPFAR PROMise Ongoing Treatment Evaluation |
SBIRT | Screening, Brief Intervention, and Referral to Treatment |
SMILE | Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children |
START | Strategic Timing of AntiRetroviral Treatment |
Download Guidelines
- Section OnlyPDF (79.99 KB)
- Full GuidelinePDF (3.95 MB)
- Recommendations OnlyPDF (313.39 KB)
- Tables OnlyPDF (755.71 KB)
- Drug Tables OnlyPDF (775.81 KB)